# Real-World Cost–Effectiveness of Primary Prophylaxis with G-CSF Biosimilars in Patients at Intermediate/High Risk of Febrile Neutropenia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-cost-effectiveness-of-primary-prophylaxis-with-g-csf-biosimilars-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paul Cornes,John M. Kelton,Rongzhe Liu,Omer Zaidi,Jennifer Stephens,Jingyan Yang |
| Citations | 6 |
| DOI | 10.2217/fon-2022-0095 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.2217/fon-2022-0095 |
| OpenAlex ID | https://openalex.org/W4220710222 |
| PMID | 35354304 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Omer Zaidi](https://scholariq.org/researchers/omer-zaidi/)

## Paper journal

- [Future Oncology](https://scholariq.org/journals/future-oncology/)

## Paper primary topic

- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)

## Paper topics

- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)
- [Blood disorders and treatments](https://scholariq.org/topics/blood-disorders-and-treatments/)
- [Chemotherapy-related skin toxicity](https://scholariq.org/topics/chemotherapy-related-skin-toxicity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.